Trial Profile
A phase I/II study of ISA101 [ISA HPV 01] in patients with cervical cancer
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 30 May 2014
Price :
$35
*
At a glance
- Drugs ISA 101 (Primary)
- Indications Cervical cancer; Human papillomavirus infections
- Focus Adverse reactions; Pharmacodynamics
- 30 May 2014 New trial record